Service Overview
Design and evaluation of multi-epitope vaccine candidates using immunoinformatics.
What Is This Service?
Immunoinformatic vaccine design utilizes information from target proteins to identify promising B-cell, cytotoxic T-cell, and helper T-cell epitopes, subsequently integrating them into a rational vaccine design. This represents a rapid computational approach for developing vaccine candidates during the early stages.
How Does This Service Help You?
This service supports researchers working on infectious diseases, emerging pathogens, veterinary pathogens, cancer targets, and immunology projects. It reduces the number of candidates requiring experimental testing and helps select vaccine designs that are safer and more likely to stimulate an immune response.
What Do You Receive From Us?
You receive epitope prediction and screening tables, population coverage analysis when needed, a proposed multi-epitope vaccine design, structural validation, docking with immune receptors or immune-response simulations when included, and codon optimization or virtual cloning upon request. Each project is delivered within a maximum of one week. You also receive a complete publication-ready scientific report covering materials, methods, results, discussion, references, clear tables, and high-quality figures when needed, with full support through publication, including assistance responding to reviewer and journal comments.
Service Benefits
- B-cell, CTL, and HTL epitope screening
- Safety and immunogenicity filtering
- we perform analysis in max 1-week
- we follow up until publication , any reviews pr questions we can revise and replay
- Complete vaccine construct interpretation
- Publication-ready report within one week plus full journal follow-up
- you receive a complete report , material and method . result , discussion and references with publishable resolution figures